Breaking News

You are here » Indian-Commodity  :  Commodities  :  Pepper Commodities Decrease On Gain Taking

16-May2011

Pepper Commodities Decrease On Gain Taking

Pepper commodities are dealing minimal on Monday because of earnings booking, the costs increased in a week ago on solid requirement among tight supply in the worldwide markets and local markets, offering chance of profit acquiring at greater levels.

The deal for May supply was dealing at Rs 30325.00, lower by 0.35% or Rs 105.00 from their earlier ending of Rs 30430.00. The available awareness of settlement was standing at 6335 lots.

The settlement for June supply was exchanging at Rs 30180.00, out by 0.65% or Rs 198.00 from their past finishing of Rs 30378.00. The available interest of the settlement was standing at 14614 tons on NCDEX.

Related News

View all news

BT Cotton Seeds Businesses Targeting Earnings Of Rs 700 Crore This Season

BT Cotton seeds organizations are targeting earnings of Rs 700 cr this season as a result of a rise ......

Gold Challenges To Maintain Earlier Increases As The Problems In Europe Prolongs

Gold prices surrounded reduce on Monday because the euro solved their deficits in opposition to the ......

Copper Seems To Lengthen Uptrend As Dollar Recoils

Copper rates were able to lengthen the uptrend for 3rd instantly period on Monday, as traders proved......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......